Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iovance Biotherapeutics (IOVA) Preferred Shares: 2013-2025

Historic Preferred Shares for Iovance Biotherapeutics (IOVA) over the last 6 years, with Sep 2025 value amounting to $2,000.

  • Iovance Biotherapeutics' Preferred Shares was N/A to $2,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $2,000, marking a year-over-year change of. This contributed to the annual value of $3,000 for FY2024, which is negligibly% changed negligibly from last year.
  • As of Q3 2025, Iovance Biotherapeutics' Preferred Shares stood at $2,000, which was down 0.00% from $2,000 recorded in Q2 2025.
  • In the past 5 years, Iovance Biotherapeutics' Preferred Shares ranged from a high of $3,000 in Q1 2023 and a low of $2,000 during Q1 2025.
  • For the 3-year period, Iovance Biotherapeutics' Preferred Shares averaged around $2,667, with its median value being $3,000 (2024).
  • Data for Iovance Biotherapeutics' Preferred Shares shows a maximum YoY crashed of 33.33% (in 2025) over the last 5 years.
  • Iovance Biotherapeutics' Preferred Shares (Quarterly) stood at $3,000 in 2023, then remained steady at $3,000 in 2024, then slumped by 33.33% to $2,000 in 2025.
  • Its last three reported values are $2,000 in Q3 2025, $2,000 for Q2 2025, and $2,000 during Q1 2025.